oc-101
Generic: AAV-NGF·Code: OC-101
oc-101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oyster Point Pharma, Inc. (OYST) | Preclinical |
Get deeper analysis on oc-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis